Figure 2. Time to Disease Progression and First Relapse Among Patients Receiving Hematopoietic Stem Cell Transplantation vs Disease-Modifying Therapy.
Median follow-up time was 24 months (interquartile range, 12-48 months).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.